Bharat Biotechs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bharat biotechs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bharat Biotechs Today - Breaking & Trending Today

Brazil suspends Bharat Biotech's Covaxin clinical trials : The Tribune India


1085
Hyderabad, July 24
Brazil has suspended the clinical studies of Bharat Biotech’s Covid-19 vaccine, Covaxin following termination of the company’s agreement with its partner there, the South American Country’s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
“In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil ....

United States , Andhra Pradesh , Precisa Medicamentos , Coordination Of Clinical Research At Anvisa Copec , Bharat Biotech Limited International , Envixia Pharmaceuticals , Bharat Biotech , South American Country , Clinical Research , Bharat Biotechs , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , பாரத் பயோடெக் , தெற்கு அமெரிக்கன் நாடு , மருத்துவ ஆராய்ச்சி ,

Brazil suspends Covaxin clinical trials after Bharat Biotech cancels contracts with its partner


Brazil suspends Covaxin clinical trials after Bharat Biotech cancels contracts with its partner
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities.
Share Via Email
  |  A+A A-
By PTI
HYDERABAD: Brazil has suspended the clinical studies of Bharat Biotech s COVID-19 vaccine, Covaxin following termination of the company s agreement with its partner there, the South American Country s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market. ....

United States , Andhra Pradesh , Lok Sabha , Precisa Medicamentos , Coordination Of Clinical Research At Anvisa Copec , Bharat Biotech Limited International , Envixia Pharmaceuticals , Health Bharati Pravin Pawar , Health Ministry Of India , Bharat Biotech , South American Country , Clinical Research , Brazil The , Bharat Biotechs , Health Ministry , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , லோக் சபா , ஆரோக்கியம் அமைச்சகம் ஆஃப் இந்தியா , பாரத் பயோடெக் , தெற்கு அமெரிக்கன் நாடு , மருத்துவ ஆராய்ச்சி , பிரேசில் தி , ஆரோக்கியம் அமைச்சகம் ,